Dry eye diagnostic coming to a clinic near you

Article

OcuSense, makers of the innovative TearLab Osmolarity System for the diagnosis of dry eye, announced the signing of multi-year agreements with four distributors in five EU countries, for the exclusive distribution of the TearLab system.

OcuSense, makers of the innovative TearLab Osmolarity System for the diagnosis of dry eye, announced the signing of multi-year agreements with four distributors in five EU countries, for the exclusive distribution of the TearLab system.

The countries involved include: the UK and Ireland (Birmingham Optical Group); Germany (bon Optic), Spain (Equipsa); and Italy (SIFI Diagnostics).

The TearLab System determines osmolarity through measurement of electrical impedance of tear samples. It uses a lab-on-a-chip approach: the disposable tip not only takes the tiny tear film samples, less than 50 nL, from the eye but also contains electrodes that rapidly measure tear osmolarity. It takes about 30 seconds to perform the test from start to finish, and can be done by a technician. Thus the test can be easily performed in the office and only a tiny tear sample is required.

A multicentre study with the system is scheduled to begin later this year in six European sites: the UK, Germany, France, Italy, and Spain, as well as three sites in the US and one in Japan.

Related Videos
Ana Neves, head of global marketing for ZEISS Meditec Ophthalmology
Kasperi Kankare at the iCare booth at ESCRS
Scott D Barnes, MD, CMO of STAAR Surgical
Tomislav Bucalic, head of marketing at Geuder, and David Geuder, member of the executive board and CIO
Thomas Bosshard stands at the Oertli Instruments booth at the ESCRS meeting
Eva Kim, MD, speaks about her presentation on ICL versus CLE at the Women in Ophthalmology Summer Symposium 2023 in Marco Island, Florida.
© 2024 MJH Life Sciences

All rights reserved.